002755.SZ announcement that Jiangsu Ausaikang Pharmaceutical Co., Ltd., a wholly owned subsidiary of the company, recently received.
Zhitong Financial APP News, 002755.SZ notice, Jiangsu Aosaikang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the "Drug Registration Certificate" of temozolomide capsule issued by the State Drug Administration ("FDA").
It is reported that temozolomide is a kind of imidazolo tetraazine alkylating agent, the main indication is newly diagnosed pleomorphic glioblastoma, first combined with radiotherapy, then as maintenance therapy; recurrent or progressive pleomorphic glioblastoma (GBM) or anaplastic astrocytoma after conventional treatment.